Pricing

Neil Kumar

Co-Founder at Bridgebio Pharma LLC

Neil Kumar

Neil Kumar

Co-Founder at Bridgebio Pharma LLC

Overview

Career Highlights

Eidos Therapeutics, Inc.
Bridgebio Pharma LLC

RelSci Relationships

2179

Number of Boards

3

Contact Data

Trying to get in touch with Neil Kumar? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

Relationships

View Relationship Details

RelSci Relationships are individuals Neil Kumar likely has professional access to. A relationship does not necessarily indicate a personal connection.

Brian M. Stolz

Chief Operating Officer at BridgeBio Pharma, Inc.

Relationship likelihood: Strong

Ervin Epstein

Co-Founder at PellePharm, Inc.

Relationship likelihood: Strong

Jean Tang

Co-Founder & Director at PellePharm, Inc.

Relationship likelihood: Strong

Uma Sinha

Chief Scientific Officer at BridgeBio Pharma, Inc.

Relationship likelihood: Strong

Carl B. Feldbaum

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

Frank McCormick

Director at University of California - Berkeley

Relationship likelihood: Strong

Eric I. Aguiar

Partner at Aisling Capital

Relationship likelihood: Strong

Barbara H. Wells

Director & Vice Chairman-Food Governing Body at Biotechnology Innovation Organization

Relationship likelihood: Strong

William Waddill

Co-Chair at Biotechnology Innovation Organization

Relationship likelihood: Strong

Jonathan Charles Fox

President & Chief Medical Officer at Eidos Therapeutics, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

ENP Newswire

February 27, 2020

-Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business Update

ENP Newswire

February 25, 2020

-BridgeBio Pharma, Inc. Appoints Ronald J. Daniels to Its Board of Directors

ENP Newswire

December 17, 2019

-BridgeBio Pharma, Inc. Appoints Industry Leader Jennifer Cook As New Board Member

ENP Newswire

December 10, 2019

-BridgeBio Pharma, Inc. Appoints Eli Wallace as Chief Scientific Officer in Residence for Oncology Programs

ENP Newswire

December 4, 2019

-BridgeBio Pharma's Origin Biosciences Initiates Rolling Submission of New Drug application With the U.S. FDA for BBP-870 for The Treatment of MoCD Type A

Paths to Neil Kumar

Potential Connections via
Relationship Science

You

Neil Kumar

Co-Founder at Bridgebio Pharma LLC

Education

Ph.D Chemical Engineering

Massachusetts Institute of Technology

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

MS in Chemical Engineering

Stanford University

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Career History

Co-Founder

Current

Bridgebio Pharma LLC

BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA.

Chief Executive Officer & Director

Current

Eidos Therapeutics, Inc.

Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA.

Interim Head, Business Development & Operations

2012 - 2014

MyoKardia, Inc.

MyoKardia, Inc. operates as a biopharmaceutical company. It engages in the discovery, development, and commercialization of targeted therapies for the treatment of cardiovascular diseases. The firm focuses on the treatment of heritable cardiomyopathies, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It offers MYK-46, an orally-administered small molecule designed to reduce excessive cardiac muscle contractility to hypertrophic cardiomyopathy. The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in San Francisco, CA.

Transactions

Details Hidden

Eidos Therapeutics, Inc. raised money in a private placement transaction

Other Affiliations

Neil Kumar is affiliated with Bridgebio Pharma LLC, Eidos Therapeutics, Inc., MyoKardia, Inc., Third Rock Ventures LLC, McKinsey & Co., Inc., AstraZeneca Diagnostics

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Neil Kumar. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Neil Kumar's profile does not indicate a business or promotional relationship of any kind between RelSci and Neil Kumar.